About
Basic Data Updated:
20 days agoFounded in 2013, Koye Pharmaceuticals Private Limited is a leading pharmaceutical company with its registered office located in Mumbai, Maharashtra. Our company is dedicated to seeking out and identifying essential drugs in various areas of specialty such as primary care, respiratory, gynaecology, IVF, diabetology, and metabolics. Our goal is to introduce these life-saving medications to the market, providing patients with the best possible treatment options. At Koye Pharmaceuticals, we take great pride in our diverse range of products. Our portfolio includes Coecoral 250, Amucoe 100, Amucoe-NAC, Acosat, Augxetil CV 500, and benepack 8, among others. Each of these products has been carefully developed and tested to ensure the highest quality and effectiveness for our customers. Our team at Koye Pharmaceuticals is made up of dedicated and passionate individuals who are committed to making a positive impact on the healthcare industry. Through our innovative research and development, we strive to continuously improve and expand our product offerings, providing patients with the best possible care. With a strong focus on ethical practices and compliance, Koye Pharmaceuticals is committed to upholding the highest standards in the pharmaceutical industry.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U74120MH2013PTC243214 |
Company No. | 243214 |
Company Classification | Private Limited Indian Non-Government Company |
Incorporation Date | 12 May 2013 |
Date of AGM | 30 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Mumbai |
Products or Services related to Koye Pharmaceuticals Private Limited
Financials of Koye Pharmaceuticals Private Limited
Koye Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.36% increase. The company also saw a substantial improvement in profitability, with a 36.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.9%.
Corporate Structure
Unlock access to Koye Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Koye Pharmaceuticals Private Limited
Unlock and access historical data on people associated with Koye Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
MK
Mitali Kulkarni Company SecretaryAppointment Date: 23-Jan-2019
Status: Current
Board Members(4)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 27 Feb 2023 | ₹20.00 Cr | Open |
Others Creation Date: 22 Mar 2022 | ₹36.85 Cr | Open |
Others Creation Date: 17 Mar 2022 | ₹9.80 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koye Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koye Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Koye Lifesciences Private Limited
Active 2 years 1 monthRavindra Shenoy and Preetish Toraskar are mutual person
Recent activity within the organization
Director Appointment
Nikhil Tambolkar was appointed as a Nominee Director was appointed as a Nominee Director on 26 Apr 2024 & has been associated with this company since 21 days .
26 Apr 2024Charges
A charge registered on 13 Jul 2020 via Charge ID 100397886 with Others was fully satisfied on 11 Mar 2024.
11 Mar 2024Charges
A charge registered on 11 Mar 2020 via Charge ID 100336324 with Others was fully satisfied on 13 Dec 2023.
13 Dec 2023Charges
A charge registered on 30 Nov 2018 via Charge ID 100224844 with Others was fully satisfied on 02 Dec 2023.
02 Dec 2023Annual General Meeting
Koye Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023
Recent News, Updates & Announcement
- Shakeup in China industry disrupts vitamin C supply in India Mint.
Supply disruptions have also been witnessed with popular chewable vitamin C tablet LimceeLimcee Plus has vitamin C and amino acid and thus does not only target patients who suffer from vitamin C deficiency.
mint 30 Apr 2019
- PremjiInvest bets on Sequoiabacked Koye Pharmaceuticals.
VCCircle 27 Nov 2018
- based Koye Pharmaceuticals raises fresh capital .
VCCircle 09 Aug 2017
- InnoVen Capital India loaned 12 million to eight startups in Q1 Mint.
InnoVen Capital India aims to disburse about 6065 million in venture debt in 2016.
mint 06 Jul 2016
Frequently asked questions
What is the Incorporation or founding date of Koye Pharmaceuticals Private Limited?